Sylentis, S.A.
12 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety Study of Tivanisiran to Treat Dry Eye (NCT05310422) | Sylentis, S.A. | 2022-03-24 |
| Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome (NCT04819269) | Sylentis, S.A. | 2021-05-25 |
| Safety, Tolerability and Pharmacokinetic Profile of SYL1801 Eye Drops (NCT04782271) | Sylentis, S.A. | 2021-03-17 |
Track Sylentis, S.A. automatically
Every clearance here is in the API, with alerts when new ones post.